tradingkey.logo
tradingkey.logo
Search

Aditxt Subsidiary Pearsanta Receives Irb Approval To Initiate Clinical Study Of Blood-Based Diagnostic For Endometriosis With Patient Enrollment Planned To Begin In May 2025

ReutersApr 16, 2025 1:08 PM
facebooktwitterlinkedin

- Aditxt Inc ADTX.O:

  • ADITXT SUBSIDIARY PEARSANTA RECEIVES IRB APPROVAL TO INITIATE CLINICAL STUDY OF BLOOD-BASED DIAGNOSTIC FOR ENDOMETRIOSIS WITH PATIENT ENROLLMENT PLANNED TO BEGIN IN MAY 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI